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ABSTRACT 
 
     Polyamines are a class of essential nutrients involved in many basic cellular processes such as 
gene expression, cell proliferation, and apoptosis.  Without polyamines, cell growth is delayed or 
halted.  Cancerous cells require an abundance of polyamines through a combination of synthesis 
and transport from the extracellular environment.  An FDA-approved drug, D,L-α-
difluoromethylornithine (DFMO), blocks polyamine synthesis but is ineffective at inhibiting cell 
growth due to polyamine transport. Thus, there is a need to develop drugs that inhibit polyamine 
transport to use in combination with DFMO. Surprisingly, little is known about the polyamine 
transport system in humans and other eukaryotes.  Understanding the transport system would allow 
us to identify compounds that inhibit polyamine transport, which could then be used in tandem 
with DFMO to treat cancer.  Our laboratory has identified one gene in Drosophila, called 
CG32000, as a component of this transport system, and numerous other candidate genes remain to 
be tested. 
     To better characterize this system, this project investigated the ability of the Drosophila 
transport system to take up a toxic polyamine analogue called norspermidine, with the initial goal 
of developing a new screening method to find polyamine transport genes. My experiments have 
demonstrated significant differences in norspermidine uptake and toxicity between C. elegans and 
Drosophila which may imply a secondary polyamine transport system in higher eukaryotes. In the 
long term, it is hoped that this thesis will facilitate the development of more effective cancer 
medications by providing new information about the polyamine transport system.  
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INTRODUCTION 
 
Physiological Roles of Polyamines: 
 
Polyamines are a class of crucial nutrients that are involved in many cell processes such as gene 
expression and cell growth and cell death (Childs, 2003).  Common polyamines include putrescine, 
spermine, and spermidine.  In mammals, spermine and spermidine are present in much higher 
levels than putrescine, from which they are synthesized (Pegg, 2009).  At physiological pH, 
polyamines are polycationic and therefore able to interact with negatively charged regions of 
macromolecules such as DNA and RNA.  Because of these interactions, polyamines have been 
implicated in the synthesis, stability, and transcription of DNA, as well as ion channel regulation 
and phosphorylation of proteins (Hochman, 1978; Tabib, 1994; Panagiotidis, 1995; Childs, 2003). 
On a broader level, studies suggest that polyamines play a role in longevity and stress response 
(Eisenberg, 2009; Rhee, 2007; Minois, 2011). Polyamines are present in all cells and levels of 
polyamines are carefully regulated, indicating their universal importance (Russell, 1983).  
Regulation of polyamine levels is accomplished through synthesis, transport, and catabolism.  
Regulation of Polyamine Levels: 
 
The polyamine synthesis pathway begins with arginine and methionine (Figure 1). Arginase 
converts arginine to ornithine, which is then converted to putrescine by ornithine decarboxylase 
(ODC) (Hochman, 1978; Tabib, 1994; Panagiotidis, 1995; Childs, 2003). Methionine is converted 
to S-adenosyl-L-methionine, decarboxylated, and then added to putrescine to produce spermidine 
or to spermidine to produce spermine. The pathway can also be reversed to produce putrescine 
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from spermine or spermidine. The conversion of ornithine to putrescine by ODC is a crucial step 
in this pathway. Transcription of the ODC gene is tightly regulated and the ODC protein is post-
translationally regulated. The ODC antizyme inhibits ODC and facilitates its degradation (Minois, 
2011). These mechanisms ensure that cells maintain proper levels of polyamines. 
 
 Figure 1: Regulation of cellular polyamine levels. Cells maintain the necessary levels of polyamines through 
synthesis from arginine and S-adenosylmethionine and through polyamine transport. (Soda, 2011). 
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Polyamines and Disease: 
 
Polyamine metabolism is important in several human pathologies. Leishmaniasis is a neglected 
tropical disease caused by the Leishmania parasite, and an estimated 2 million cases occur 
annually, often resulting in lasting disability (Desjeux, 2001). Levels of putrescine, spermidine, 
and spermine fluctuate during the cell cycle of the Leishmania parasite and peak during 
logarithmic growth, indicating the importance of polyamines in their development (Bachrach, 
1979). The malarial parasite also depends on high levels of polyamine biosynthesis for 
development and synthesis of proteins and amino acids, because its human erythrocyte host cells 
lack the enzymes needed to synthesize polyamines (Assaraf, 1984).  The protozoan T. cruzi is the 
causative agent for Chagas’ disease, a neglected tropical disease that affects 8 million people 
worldwide and for which few effective drug treatments are available (Bern, 2011). Unlike other 
protozoans, T. cruzi depends solely on polyamine transport to obtain polyamines and will die if its 
supply is lost, making the polyamine transport system in T. cruzi a promising target for new drugs 
(Reigada, 2017). Multi-drug resistant Mycobacterium tuberculosis is yet another emerging world 
health concern, and a 2013 study suggests that polyamines may be a contributing factor (Sarathy, 
2013). Beyond pathogenic diseases, polyamines have been linked to inflammatory diseases, liver 
disease, stroke, Alzheimer and Huntington’s disease (Hussain, 2017; Minois, 2011). 
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Polyamines and Cancer: 
 
Polyamines play a significant role in cancer. Because of their high rate of growth, cancer cells 
require high levels of polyamines (Luk, 1987).  This is reflected by increased levels of blood and 
urine polyamines in cancer patients.  Blood and urine polyamine levels return to normal levels 
once the cancer has been completely eradicated (Loser, 1990; Chatel, 1987; Kubota, 1985; Uehara, 
1980). It has further been noted that higher polyamine levels in the blood and urine correspond 
with more severe prognoses (Durie, 1977).  An increased capacity to synthesize polyamines 
correlates with increased production of proteinases to degrade tissues around a tumor resulting in 
higher levels of extracellular polyamines. Immune cells in the high polyamine environment of the 
tumor show reduced anti-tumor function which may be related to high levels of polyamines (Soda, 
2011). Thus, blocking the supply of polyamines to cancer cells presents a promising therapeutic 
strategy.  
An existing polyamine synthesis-blocking, FDA-approved drug called difluoromethylornithine 
(DFMO) has shown promise in treating cancer, especially pancreatic cancer (Mohammed, 2014).  
This is noteworthy because pancreatic cancer was the third leading cause of cancer deaths in the 
United States in 2016 (Siegel, 2016).  Pancreatic cancer is especially dangerous because physical 
symptoms – such as weight loss and fatigue – are not specific to the disease, which complicates 
diagnosis and delays treatment.  When the cancer is finally diagnosed, few effective treatments are 
available.  
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Polyamine Transport: 
 
While DFMO is a promising treatment option, it is limited as a chemotherapeutic agent because 
malignant cells are also able to transport polyamines from their environment.  The polyamine 
transport system (PTS) is understood in E.coli (Kashiwagi, 1995), yeast (Uemura, 2005), and some 
unicellular protozoans (Marie-Pierre, 2005; Machius, 2007). In these organisms, polyamine 
transport is controlled by a complex of proteins: for example, in E. coli the proteins potB and -C 
form a channel while potA and -D coordinate with them to control spermidine uptake (Kashiwagi, 
1995). However, only a few scattered components of the polyamine transport system in 
multicellular animals have been identified (Belting, 2003; Uemura, 2008; Heinick, 2010; Hiasa, 
2014), and the overall mechanism is not yet understood. Currently, there are three principle 
proposed models of polyamine transport, as discussed in a review by Poulin et al (Poulin, 2012): 
glypican-1-dependent endocytosis (Belting, 2003), caveolin-mediated endocytosis utilizing an 
unidentified receptor (Uemura, 2010), and entry via an energy-dependent channel or transporter 
followed by packaging into endosomes for storage (Soulet, 2004). The three models are not 
necessarily mutually exclusive, and polyamine transport may occur via combinations of these 
models. Therefore, elucidating the polyamine transport system in eukaryotes would facilitate the 
development of a transport inhibitor to be used in conjunction with DFMO.   
As part of our effort to understand the PTS in Drosophila, our laboratory has identified a gene, 
CG32000, that is required for polyamine transport and which has a human orthologue, ATP13A3.  
CG32000 encodes a type P5B-ATPase, a subfamily of proteins whose function was previously 
unknown.  CG32000 encodes multiple proteins via alternative splicing and therefore may encode 
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a family of polyamine transporters. A closely related P5A-ATPase encoded by CG6320 was not 
found to play a role in transport, indicating a high level of specificity and providing a useful 
control.  Based on the complexes observed in E. coli and yeast, polyamine transport in higher 
organisms is also likely to involve a complex of proteins and therefore it is important to identify 
additional genes required for polyamine transport. Additionally, as our laboratory continues to 
investigate the role of CG32000, identifying its partners will facilitate our understanding. 
The DFMO Assay: 
 
Previous studies have indicated that the polyamine transport system in Drosophila is highly 
comparable to that of vertebrates, making Drosophila a good model for understanding the PTS 
(Tsen, 2008; Wang et al 2017).  Our laboratory currently uses a DFMO based assay for screening 
candidate genes which involves knocking out the gene of interest in Drosophila using RNAi.  To 
achieve this, fly strains are engineered so that one strain expresses the GAL4 transcription factor, 
a protein found originally in yeast, linked to a ubiquitously expressed promoter such as that for 
actin (Figure 2).  This strain is crossed with another strain that contains an upstream activating 
sequence (UAS) that binds GAL4 upstream of a sequence that will produce double stranded RNA 
(dsRNA) complimentary to the gene of interest.  When the GAL4 and the UAS sequences are 
present in the same animal, Gal4 activates transcription of the dsRNA, which is processed by Dicer 
and used to degrade RNA transcribed from the gene of interest.  In this way, the functions of genes 
that may be otherwise lethal can be tested without maintaining a stock of mutant animals (Duffy, 
2002).  Once flies with the desired gene knockout have been bred, the offspring larvae are grown 
in the presence of DFMO and polyamines.  DFMO disables their ability to synthesize polyamines, 
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forcing them to transport to survive.  Because polyamines are added to the fly media, animals with 
a functional transport system can transport polyamines and survive in the presence of DFMO. If a 
crucial transport gene has been knocked out, the animals will be unable to transport and will die. 
  
Figure 2: GAL4/UAS system in Drosophila. Flies expressing the GAL4 transcription factor are crossed with flies 
expressing an Upstream Activating Sequence (UAS) that binds GAL4 to allow transcription of the desired gene or 
dsRNA for RNAi. (Caldwell, 2013). 
 
While the DFMO assay is useful, it has several limitations. Genes must be tested individually, and 
several treatment conditions must be set up for each gene because of the various controls used. 
Because the majority of the larvae will survive and must be counted at least daily over the course 
of 2-3 weeks, tracking the results of the assay is similarly labor-intensive.  
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An Alternative Approach: 
 
Norspermidine, a toxic polyamine, presented a promising alternative screening method.  
Norspermidine is an analog of spermidine, differing by only one carbon atom.  In C. elegans, it 
was used in an assay to find the polyamine transport gene CATP-5, an ortholog of Drosophila 
CG32000 (Heinick, 2010).  In an assay similar to the DFMO assay described above, nematodes 
were exposed to norspermidine, and worms with a functional transport system did not survive.  
Mutants with a nonfunctional transport system, however, were able to survive when grown in the 
presence of lethal levels of norspermidine.  The work demonstrated that CATP-5 was necessary 
for norspermidine uptake. As this discovery led to the identification of CG32000 as a polyamine 
transport system component in Drosophila, a norspermidine assay appeared to be a promising 
approach to identifying additional components. If a norspermidine assay could be replicated in 
Drosophila, it would only require two treatment conditions to test a gene (the lethal concentration 
of norspermidine and the control), and vials could be rapidly checked for survivors that would 
indicate a positive result. Additionally, multiple fly strains with different gene knockdowns could 
be tested in the same vials and either eliminated together or tested individually if survivors were 
observed. All other advantages aside, a norspermidine assay could simply provide a second line of 
evidence to confirm results from the DFMO assay. 
In this study, I investigated the effect of norspermidine on Drosophila lines with functional and 
nonfunctional transport systems and determined the feasibility of developing a norspermidine 
assay in Drosophila to screen for genes associated with the polyamine transport system.   
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METHODS 
 
Determining the lethal dose of norspermidine for Drosophila:  
 
To investigate whether disrupting CG32000 conferred norspermidine resistance, the lethal 
concentration of norspermidine for wild-type OreR flies was first identified to provide a point of 
comparison.  
200 female OreR flies and 50 males were allowed to breed and lay their eggs on an agar plate 
containing grape juice, which provided an ideal environment for larval growth and subsequent 
collection. The following protocol was used to produce these grape plates: 376 mL ddH2O and 
126 mL grape juice were added to a 2 L flask along with a magnetic stir rod. The mixture was 
stirred until homogenous and 15 g agar and 6 g sucrose were then added. The flask was covered 
with aluminum foil and heated at 450 degrees C until boiling occurred, after which it was removed 
from the hot plate for 5 minutes. The flask was then placed again on the hot plate and stirred until 
the contents reached 60 degrees C. 10 mL of 100% ethanol and 5 mL glacial acetic acid were 
added, and the flask was stirred for an additional 3 minutes. The mixture was poured into Petri 
dishes and left overnight to set before being stored at 4 degrees C until used.  
A small amount of yeast paste (made from instant yeast and water) was applied to each grape plate 
to provide food for the adult flies. Grape plates were replaced regularly to ensure that sufficient 
numbers of eggs would be obtained and cleared of larvae and yeast paste 4 hours before collection 
so that larvae would emerge synchronously. Larvae were collected at the first instar stage and 
placed into vials containing jazz mix medium (a standard fly food containing yeast, agar, cornmeal, 
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and sugar) obtained from Fisher Scientific and varying concentrations of norspermidine, with 50 
larvae per vial.  
Vials were prepared as follows: 
 
226.8 𝑔 𝑗𝑎𝑧𝑧 𝑚𝑖𝑥
1050 𝑚𝐿 𝑡𝑜𝑡𝑎𝑙 𝑓𝑜𝑜𝑑
× (# 𝑜𝑓 𝑣𝑖𝑎𝑙𝑠) × 6.0 𝑚𝐿 𝑓𝑜𝑜𝑑 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 = 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑗𝑎𝑧𝑧 𝑚𝑖𝑥 𝑛𝑒𝑒𝑑𝑒𝑑 
1200 𝑚𝐿 𝐻2𝑂
1050 𝑚𝐿 𝑡𝑜𝑡𝑎𝑙 𝑓𝑜𝑜𝑑
 × (# 𝑜𝑓 𝑣𝑖𝑎𝑙𝑠)  × 5.4 𝑚𝐿 𝑓𝑜𝑜𝑑 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 = 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑛𝑒𝑒𝑑𝑒𝑑  
Jazz mix and water were combined in a 500 mL Erlenmeyer flask along with a magnetic stir rod, 
covered with aluminum foil, and heated at 415 degrees C until boiling. The temperature was then 
reduced to 225 degrees C for 10 minutes before being pipetted into vials, with 5.4 mL per vial. 
Vials were then placed in a 55-degree C water bath for 10 minutes. 98% norspermidine (obtained 
from Sigma-Aldrich and stored at 20 degrees C) was then added in the appropriate concentrations 
and each vial was mixed thoroughly. Vials were allowed to cool at room temperature for at least 
30 minutes and any condensation was removed before larvae were added.  
Strains used in norspermidine sensitivity experiments: 
 
OreR:  This strain is considered to be wild-type.  
CG6230: CG6230 encodes a highly similar protein to CG32000 that is not transport-related. RNAi, 
together with the Gal4 system, was used to produce a ubiquitous targeted gene knockdown.   
CG32000 B exon: This strain has a 2 kilobase mobile element insertion in the B exon of CG32000. 
To verify that the insertion disrupted CG32000 activity and prevented polyamine transport, larvae 
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were exposed to DFMO and polyamines in the following combinations and concentrations (Table 
1): 
Table 1: Drug concentrations for DFMO assay. 
 Treatment 
1 
Treatment 
2 
Treatment 
3 
Treatment 
4 
Treatment 
5 
Treatment 
6 
Contents: ddH2O 5 Mm 
DFMO 
0.4 mM 
Putrescine 
0.4 mM 
Putrescine 
5 mM 
DFMO 
0.2 mM 
Spermidine 
0.2 mM 
Spermidine 
5 mM 
DFMO 
 
CG32000 RNAi: A strain expressing RNAi against CG32000 was also tested. The experimental 
design was the same as for the CG32000 B exon. 
Determination of Developmental Profiles: 
 
OreR larvae were exposed to 0, 5, 10, 15, 20, 25, and 30 mM norspermidine and adult flies were 
counted daily to determine the wild-type developmental profile under each condition. B exon 
larvae were then exposed to the same concentration and their developmental profile was similarly 
observed. 
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RESULTS 
 
Determination of a Lethal Concentration of Norspermidine to Drosophila: 
 
In C. elegans the lethal concentration of norspermidine is 3 mM (Heinick, 2010). I therefore grew 
wild-type Drosophila OreR strain larvae in media containing 0, 1, 2, 3, 4, and 5 mM 
norspermidine. Survival rates at these concentrations of norspermidine are shown in Figure 3. 
Surprisingly, statistical analysis (1-way ANOVA) revealed no differences in larval survival within 
this range of concentrations with 100 percent viability observed in each case. 
 
 
Figure 3:Percent survival of OreR larvae in 0-5 mM norspermidine. Each concentration was tested in triplicate. 
Error bars reflect standard error. Data were normalized with the 0 mM control set as 100%.  
 
Based on these results I tested norspermidine at higher concentrations up to 30mM (Figure 4). 
Statistical analysis (1-way ANOVA) revealed significantly reduced viability compared to the 0 
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mM control at concentrations around 10 mM and higher. Complete lethality was observed at 30 
mM. 
 
 
Figure 4:Percent survival of OreR larvae in 0-30 mM norspermidine. All concentrations were tested in triplicate. 
Error bars reflect standard error. Data were normalized with the 0 mM control set as 100%. P<0.001 for all 
concentrations above 5 mM. 
 
Knockdown of the Polyamine Transport Gene CG32000 Does Not Prevent Uptake of 
Norspermidine. 
 
Having established a lethal concentration of norspermidine I next asked if norspermidine utilizes 
the PTS to gain entry into cells. To test this hypothesis, I asked if norspermidine uptake was 
inhibited by RNAi knockdown or mutation of CG32000. Our laboratory has shown that RNAi 
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homozygous condition this mutation also blocks polyamine transport. As controls I also tested 
strain OreR and RNAi against CG6230 which encodes a related P type-5A ATPase which is not 
required for transport (Barnett and von Kalm; unpublished). Results from these experiments are 
shown in figure 5. A 1-way ANOVA revealed no statistically significant differences between the 
genotypes tested. No survivors were observed in OreR, CG6230 and CG32000 B exon mutants 
grown in 30 mM norspermidine. A few animals (5/200) survived after RNAi knockdown of 
CG32000. These data suggest that norspermidine uses an alternative transport system from 
CG32000 to gain entry to cells.  
 
Figure 5:RNAi knockdown and mutation of CG32000 does not block uptake of norspermidine. Percent survival of 
OreR, CG6230 RNAi, CG32000 B exon mutants, and CG32000 RNAi  larvae in 0 and 30 mM norspermidine. All 
experiments were performed in triplicate and error bars reflect standard error. Data was normalized with the 0 mM 
OreR control set as 100%.  
 
To ensure that the B exon and RNAi CG32000 strains were genetically intact I asked if these 
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DFMO blocks polyamine synthesis and forces larvae to rely on transport of exogenous polyamines 
to survive. If the larvae have a functional transport system, the presence of polyamines (putrescine 
and spermidine) will provide rescue. Otherwise, larvae will not survive. Data for the B exon mutant 
are shown in figure 6 (see Methods for experimental details). Lethality caused by 5 mM DFMO 
could not be rescued by exogenous putrescine or spermidine indicating that the PTS was non-
functional in these animals. Similar results were observed for RNAi against CG32000 (data not 
shown).   
 
 
Figure 6:Testing of B exon stocks. Exogeneous polyamines fail to rescue B exon CG32000 larvae grown in a lethal 
concentration of DFMO. A 1-way ANOVA revealed that changes in survival between the control and polyamine + 
DFMO conditions is statistically significant (P<0.001).  All experiments were performed in triplicate and error bars 
reflect standard error. Data were normalized with the 0 mM OreR control set as 100%.  
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Developmental Profiles of OreR and B exon CG32000 mutants in the presence of norspermidine. 
 
The surprising finding that norspermidine did not utilize the PTS involving CG32000 led me to 
ask if animals exhibited abnormal developmental profiles. If animals grown on norspermidine 
were severely developmentally delayed, then the absence of survivors for B exon and RNAi 
CG32000 in Figure 5 might reflect this rather than the use of an alternative transport system by 
norspermidine. Developmental data for OreR and the B exon mutant are shown in Figures 7 and 8 
respectively.  
For OreR, animals grown on all concentrations of norspermidine except 30 mM, which was lethal, 
began to emerge within 2 days of control 0 mM norspermidine animals. In addition, peak eclosion 
numbers (the point at which no more flies emerged) occurred at approximately the same time for 
all concentrations of norspermidine tested. For B exon mutants concentrations above 20 mM were 
lethal, however initial eclosion and peak eclosion times were similar for all concentrations tested. 
Thus, severe developmental delay does not seem to be a viable alternative explanation for my 
observations.       
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Figure 7:Developmental profile of OreR during norspermidine exposure. Cumulative average percent of adult OreR 
flies observed after each day for a range of norspermidine concentrations. The first day that adult flies were 
observed in the control is counted as Day 1. 
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Figure 8:Developmental profile of CG32000 B exon mutant flies during norspermidine exposure. Cumulative 
average percent of adult CG32000 B exon mutant flies observed after each day for a range of norspermidine 
concentrations. The first day that adult flies were observed in the control is counted as Day 1. 
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DISCUSSION 
 
The initial goal of this project was to investigate the feasibility of using norspermidine to screen 
for genes involved in polyamine transport. A major advantage of this approach over the current 
DFMO based approach used in the laboratory is that animals can only survive if they are unable 
to transport polyamines. Thus, batches of genes could be tested simultaneously and if a few 
survivors are observed the batch could be broken down to individual genes for further testing. In 
contrast in the DFMO screen animals must transport to survive and genes are tested individually 
in this survival based assay. Unfortunately, my data suggest that a norspermidine based screen will 
not be feasible in Drosophila. 
There were three major findings from my work. First, the lethal concentration of norspermidine in 
Drosophila (30 mM) is ten times higher than the lethal concentration in C. elegans (Heinick et al 
2010). Second, my data show that norspermidine gains entry to cells via an alternative mechanism 
to that used by CG32000, a gene required for polyamine transport. Third, I have shown that my 
data cannot be explained by severe developmental delay associated with uptake of norspermidine.    
     The lethal concentration of norspermidine for wild-type C. elegans was observed to be 3 mM 
(Heinick, 2010). Drosophila required ten times this amount. This may indicate an increased ability 
to export or metabolize norspermidine in Drosophila, thereby mitigating its toxicity. Alternatively, 
a separate transport system with a decreased affinity for norspermidine (compared to C. elegans) 
may also explain these results. Support for multiple transport pathways in Drosophila comes from 
recent work using a chemical approach showing that polyamine transport inhibitors differ in the 
relative abilities to block the uptake of the native polyamines (Wang et al., 2017). This study also 
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showed that a cocktail of polyamine transport inhibitors is more effective than individual inhibitors 
alone to blocking transport. One limitation of this study is that the norspermidine was not tested 
on C. elegans to confirm a similar level of toxicity as observed by Heinick et al.  
     While mutations disrupting the C. elegans gene CATP-5 enabled worms to survive even in 5 
mM norspermidine, flies with a nonfunctional CG32000 gene (the orthologue of CATP-5) showed 
no decrease in sensitivity to norspermidine compared to wild-type flies, either in terms of increased 
survival or decreased developmental delay. Exposing the same strain of flies to DFMO and 
polyamines confirmed that the flies were unable to transport native polyamines, as the presence of 
exogenous polyamines was unable to provide rescue from DFMO. Knocking down CG32000 
using RNAi yielded comparable results. One explanation may be that at sufficiently high 
concentrations, norspermidine uptake occurs via a secondary transport system. To further address 
this question it will be important to test the ability of the native polyamines to competitively inhibit 
norspermidine uptake. If an alternative transport system is used the native polyamines may not be 
able to competitively inhibit norspermidine transport.  
Finally, while the lethal concentration of norspermidine is 30mM for OreR, it is 20mM for the B 
exon mutant of CG32000 (cf. Figures 7 and 8). Overall viability is compromised in the B exon 
mutant (Barnett and von Kalm unpublished) presumably due to inability to transport polyamines. 
This coupled with exposure to norspermidine may increase the sensitivity to this compound. 
Future studies should be directed at better understanding the mechanism of norspermidine uptake 
and how it relates to polyamine transport in general. If, as recent evidence suggests (Wang et al, 
2017 and this study), there are multiple transport systems, it will be important to understand them 
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to facilitate the design of effective polyamine transport inhibitors to be used in conjunction with 
DFMO in cancer therapy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
REFERENCES 
 
Assaraf, Y. G., Golenser, J., Spira, D. T., & Bachrach, U. (1984). Polyamine levels and the activity 
of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, 
Plasmodium falciparum. Biochemical Journal, 222:3:815–819. 
 
Bachrach, U., Brem, S., Wertman, S.B., Schnur, L.F., Greenblatt, C.L. (1979). Leishmania spp.: 
Cellular levels and synthesis of polyamines during growth cycles. Experimental 
Parasitology, 48:457-463 
 
Belting, M.; Mani, K.; Jonsson, M.; Cheng, F.; Sandgren, S.; Jonsson, S.; Ding, K.; Delcros, J.-
G.; Fransson, L.A. (2003). Glypican-1 is a vehicle for polyamine uptake in mammalian 
cells: A pivotal role for nitrosothiol-derived nitric oxide. J. Biol. Chem. 278:47181–47189. 
 
Bern, C., Kjos, S., Yabsley, M. J., & Montgomery, S. P. (2011). Trypanosoma cruzi and Chagas’ 
Disease in the United States. Clinical Microbiology Reviews, 24:4:655–681. 
http://doi.org/10.1128/CMR.00005-11 
 
Caldwell, K. A., Shu, Y., Roberts, N. B., Caldwell, G. A., & O’Donnell, J. M. (2013). Invertebrate 
Models of Dystonia. Current Neuropharmacology, 11:1:16–29. 
http://doi.org/10.2174/157015913804999504  
 
23 
 
Chatel M, Darcel F, Quemener V, Hercouet H, Moulinoux JP. (1987). Red blood cell polyamines 
as biochemical markers of supratentorial malignant gliomas. Anticancer Res., 7:33–38.  
 
Childs, A. C., Mehta, D. J., Gerner, E. W. (2003). Polyamine-dependent gene expression. Cell. 
Mol. Life Sci. 60,1394-1406 
 
Desjeux, P. (2001). The increase in risk factors for leishmaniasis worldwide. Transactions of The 
Royal Society of Tropical Medicine and Hygiene, 95:3:1:239–243, 
https://doi.org/10.1016/S0035-9203(01)90223-8 
 
Duffy, J. B. (2002), GAL4 system in Drosophila: A fly geneticist's swiss army knife. Genesis, 34: 
1–15. doi:10.1002/gene.10150 
 
Durie BG, Salmon SE, Russell DH. Polyamines as markers of response and disease activity in 
cancer chemotherapy. Cancer Res. 1977, 37: 214-221. 
 
Eisenberg T, et al. (2009). Induction of autophagy by spermidine promotes longevity. Nat. Cell 
Biol, 11:1305–1314. doi: 10.1038/ncb1975. 
 
Hochman J, Katz A, Bachrach U. (1978), Polyamines and protein kinase II. Effect of polyamines 
on cyclic AMP--dependent protein kinase from rat liver. Life Sci. 22:1481–1484. doi: 
10.1016/0024-3205(78)90002-4. 
24 
 
 
Heinick, A., Urban, K., Roth, S., Spies, D., Nunes, F., Phanstiel, O., … Lüersen, K. (2010). 
Caenorhabditis elegans P5B-type ATPase CATP-5 operates in polyamine transport and is 
crucial for norspermidine-mediated suppression of RNA interference. The FASEB Journal, 
24(1), 206–217. http://doi.org/10.1096/fj.09-135889 
 
Hiasa,M.;Miyaji, T.; Haruna, Y.; Takeuchi, T.; Harada, Y.;Moriyama, S.; Yamamoto,A.; 
Omote,H.;Moriyama, Y. (2014). Identification of a mammalian vesicular polyamine 
transporter. Sci. Rep. 4:6836. 
 
Hussain, T., Tan, B., Ren, W. et al. (2017). Polyamines: therapeutic perspectives in oxidative stress 
and inflammatory diseases. Amino Acids, 49:1457. https://doi.org/10.1007/s00726-017-
2447-9 
 
Kashiwagi, K.; Endo, H.; Kobayashi, H.; Takio, K.; Igarashi, K. (1995). Spermidine-preferential 
uptake system in Escherichia coli. ATP hydrolysis by PotA protein and its association with 
membrane. J. Biol. Chem. 270:25377-25382. 
 
Kubota S, Okada M, Yoshimoto M, Murata N, Yamasaki Z, Wada T, Imahori K, Ohsawa N, 
Takaku F. (1985). Urinary polyamines as a tumor marker. Cancer Detect Prev.8:189–192.  
 
25 
 
Loser C, Folsch UR, Paprotny C, Creutzfeldt W. (1990). Polyamines in colorectal cancer. 
Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients 
with colorectal cancer. Cancer, 65:958–966. doi: 10.1002/1097-
0142(19900215)65:4<958::AID-CNCR2820650423>3.0.CO;2-Z.  
 
Luk, G. D., & Casero, R. A. (1987). Polyamines in normal and cancer cells. Advances in Enzyme 
Regulation. Retrieved November 15, 2016, from 
http://www.sciencedirect.com/science/article/pii/0065257187900070  
 
Machius,M.; Brautigam, C.A.; Tomchick, D.R.;Ward, P.; Otwinowski, Z.; Blevins, J.S.; Deka, 
R.K.; Norgard,M.V. (2007). Structural and biochemical basis for polyamine binding to the 
Tp0655 lipoprotein of Treponema pallidum: Putative role for Tp0655 (TpPotD) as a 
polyamine receptor. J.Mol. Biol. 373:681–694. 
 
Marie-Pierre, H.; Buddy, U. (2005). Identification and characterization of polyamine permease 
from the protozoan parasite Leishmania major. J. Biol. Chem. 208:15188–15194. 
 
Minois, N., Carmona-Gutierrez, D., & Madeo, F. (2011). Polyamines in aging and disease. Aging 
(Albany NY), 3:8:716–732. 
 
Mohammed, A., Janakiram, N. B., Madka, V., Ritchie, R. L., Brewer, M., Biddick, L., … Rao, C. 
V. (2014). Eflornithine (DFMO) Prevents Progression of Pancreatic Cancer by Modulating 
26 
 
Ornithine Decarboxylase Signaling. Cancer Prevention Research (Philadelphia, Pa.), 
7(12), 1198–1209. http://doi.org/10.1158/1940-6207.CAPR-14-0176 
 
Panagiotidis CA, Artandi S, Calame K, Silverstein SJ. (1995). Polyamines alter sequence-specific 
DNA-protein interactions. Nucleic Acids Res, 23:1800–1809. doi: 
10.1093/nar/23.10.1800.  
 
Pegg, A. E. (2009). Mammalian Polyamine Metabolism and Function. IUBMB Life, 61(9), 880–
894. http://doi.org/10.1002/iub.230 
 
Reigada, C., Valera-Vera, E., Sayé, M., Errasti, A., Avila, C., and Miranda, M. (2017). 
Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid 
Transporters in Trypanosoma cruzi. PLoS Neglected Tropical Diseases, 11:3:5472. 
https://doi.org/10.1371/journal.pntd.0005472  
 
Rhee, H. J., Kim, E.-J., & Lee, J. K. (2007). Physiological polyamines: simple primordial stress 
molecules. Journal of Cellular and Molecular Medicine, 11:4:685–703. 
http://doi.org/10.1111/j.1582-4934.2007.00077.x 
 
Russell D.H. Clinical relevance of polyamines. (1983). Crit. Rev. Clin. Lab. Sci, 18:261–311. doi: 
10.3109/10408368209085073. 
 
27 
 
Sarathy, J.P., Lee, E., Dartois, V. (2013). Polyamines Inhibit Porin-Mediated Fluoroquinolone 
Uptake in Mycobacteria. PLoS ONE8(6): e65806. 
https://doi.org/10.1371/journal.pone.0065806  
 
Siegel, R.L., Miller, K.D. and Jemal, A. (2016), Cancer statistics, 2016. CA: A Cancer Journal for 
Clinicians, 66: 7–30. doi:10.3322/caac.21332 
 
Soda, K. (2011). The mechanisms by which polyamines accelerate tumor spread. Journal of 
Experimental & Clinical Cancer Research : CR, 30:1:95. http://doi.org/10.1186/1756-
9966-30-95  
 
Soulet, D.; Gagnon, B.; Rivest, S.; Audette, M.; Poulin, R. (2004). A fluorescent probe of 
polyamine transport accumulates into intracellular acidic vesicles via a two-step 
mechanism. J. Biol. Chem. 279:49355–49366. 
 
Tabib, A., Bachrach, U. (1994). Activation of the proto-oncogene c-myc and c-fos by c-ras: 
involvement of polyamines. Biochem Biophys Res Commun, 202:720–727. doi: 
10.1006/bbrc.1994.1990. 
 
Tsen, C., Iltis, M., Kaur, N., Bayer, C., Delcros, J., von Kalm, L., and Phanstiel, O.  (2008). A 
Drosophila Model To Identify Polyamine−Drug Conjugates That Target the Polyamine 
28 
 
Transporter in an Intact Epithelium. Journal of Medicinal Chemistry, 51 (2), 324-330.  
DOI: 10.1021/jm701198s 
 
Uehara, N., Shirakawa,. S, Uchino, H., Saeki, Y. (1980). Elevated contents of spermidine and 
spermine in the erythrocytes of cancer patients. Cancer. 45:108–111. doi: 10.1002/1097-
0142(19800101)45:1<108::AID-CNCR2820450120>3.0.CO;2-W. 
 
Uemura, T.; Kashiwagi, K.; Igarashi, K. (2005). Uptake of putrescine and spermidine byGap1p on 
the plasma membrane in Saccharomyces cerevisias. Biochem. Biophys. Res. Commun. 
328:1028–1033. 
 
Uemura, T.; Yerushalmi, H.F.; Tsaprailis, G.; Stringer, D.E.; Pastorian, K.E.; Hawel, L.; Byus, 
C.V.; Gerner, E.W. (2008). Identification and characterization of a diamine exporter in 
colon epithelial cells. J. Biol. Chem. 283:26428–26435. 
 
Wang, M., Phanstiel, O., von Kalm, L. (2017). Evaluation of Polyamine Transport Inhibitors in a 
Drosophila Epithelial Model Suggests the Existence of Multiple Transport Systems. 
Medical Sciences. 5:4:27. 
 
